| Mrs Margaret Groff, MD | |
|
310 Lambs Gap Rd, Mechanicsburg, PA 17050-2522 | |
| (717) 591-1425 | |
| (717) 591-1365 |
| Full Name | Mrs Margaret Groff |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 310 Lambs Gap Rd, Mechanicsburg, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073506945 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD034743E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Margaret Groff, MD 205 Grandview Ave, Suite 210, Camp Hill, PA 17011-1708 Ph: (717) 972-7917 | Mrs Margaret Groff, MD 310 Lambs Gap Rd, Mechanicsburg, PA 17050-2522 Ph: (717) 591-1425 |
News Archive
During the next three years, researchers at Case Western Reserve University will team with NASA Glenn Research Center and firefighters nationally, from Cleveland to Oregon, to design and test sensors aimed at protecting firefighters from respiratory damage and illnesses.
A grant from the McClay Foundation will enable Queen's researchers to work with clinicians to offer fast diagnostic testing to prevent meningitis and sepsis in maternity wards for the first time in Malawi.
A team from the University of Pennsylvania, Children's Hospital of Philadelphia, and University of Wisconsin-Madison are launching a project to develop new strategies for treating vision disorders using cells implanted in the retina.
BIOASIS TECHNOLOGIES INC., a pioneering biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-‐brain barrier (BBB), announces the results from an animal ischemic stroke model performed at the National Research Council Canada with the biOasis Transcend carrier peptide, MTfp and siRNA (MTfp-‐siRNA).
QLT Inc. today announced final 24-month results from the Phase II RADICAL study (Reduced Fluence Visudyne Anti-VEGF-Dexamethasone In Combination for AMD Lesions) in patients with exudative (wet) age-related macular degeneration. The purpose of the study was to determine if Visudyne® combined with Lucentis® reduced retreatment rates compared with Lucentis monotherapy, while maintaining similar vision outcomes and an acceptable safety profile.
› Verified 7 days ago
Dr. Banani Saha, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2140 Fisher Rd, Mechanicsburg, PA 17055 Phone: 717-766-1795 Fax: 717-697-6575 | |
Kapil Pruthi, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2140 Fisher Rd, Mechanicsburg, PA 17055 Phone: 717-766-1795 Fax: 717-697-6575 | |
Dwight Ira Michael, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2140 Fisher Rd, Mechanicsburg, PA 17055 Phone: 717-766-1795 Fax: 717-697-6575 | |
Eric Seidel, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 107 S Sporting Hill Rd, Mechanicsburg, PA 17050 Phone: 717-943-1781 Fax: 717-943-1782 | |
Dr. Vanitha Evangeline Abraham, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 107 S Sporting Hill Rd, Mechanicsburg, PA 17050 Phone: 717-943-1781 Fax: 717-943-1782 | |
Dr. Carrie Beth Ent, DNP, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 University Ave, Mechanicsburg, PA 17055 Phone: 717-691-6035 |